UV Infection Control Devices Market to Hit US$ 524.84 million by 2026 | DocMorris, Optum Rx Inc., Giant Eagle Inc., The Kroger Co., Rowlands Pharmacy, Walmart Stores Inc., Walgreen Co.

The demand for UV infection control devices is on a rise, owing to increase in government focus on infection control programs and surge in prevalence of hospital acquired infections (HAI).

The global UV infection control devices market size was valued at $317.42 million in 2018, and is projected to reach $524.84 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6472

Focus of governments on infection control programs, surge in prevalence of hospital acquired infections (HAI), and increase in adoption of technologically advanced UV equipment drive the growth of the global UV infection control devices market. However, high costs and strict government regulations hinder the market growth. On the other hand, untapped potential in emerging countries create new opportunities in coming years.

UV infection control devices emit ultraviolet rays that can kill infection causing microorganisms present in various healthcare facilities such as hospitals, clinics, and others. Furthermore, there are different types of UV infection control devices available in the market. For instance, mobile UV infection control devices are portable and can be moved from one place to another easily. In addition, the devices have handles all around which aid in the movement of device from one location to another. However, station type UV infection control devices are designed to plug into a standard power outlet. Moreover, these devices work by reflecting UV light off the walls. This reflected light is then absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.

Rise in government focus on infection control programs, increase in the prevalence of hospital-acquired infections, and rise in adoption of technology advanced UV equipment fuel the growth of the global UV infection control market. On the other hand, high cost of UV infection control devices and stringent government regulation restrain the growth to some extent. However, high growth prospects in emerging markets is expected to create lucrative opportunities in the near future.

The mobile segment to lead the trail by 2027-

Based on type, the mobile segment contributed to more than two-fifths of the global UV infection control market share in 2018. The segment is expected to rule the roost till 2026. In addition, the same segment would cite the fastest CAGR of 7.3% throughout the forecast period. This is attributable to surge in the prevalence of hospital-acquired infections across the globe and benefits associated with mobile UV infection control devices.

The end user segment to dominate during the estimated period-

Based on end user, the hospital segment held the major share in 2018, generating nearly half of the global UV infection control market. The segment is anticipated to maintain its dominance throughout the forecast period. Moreover, the same segment would showcase the fastest CAGR of 6.8% during the study period. This is attributed to the fact that hospitals receive different types of patients that require surgeries, which leads to increase the adoption of UV infection control devices and therefore drives the growth of the segment.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6472

Key players of the global UV infection control devices market analyzed in the research include CVS Health Corporation, Express Scripts Holding Company, DocMorris, Optum Rx Inc., Giant Eagle Inc., The Kroger Co., Rowlands Pharmacy, Walmart Stores Inc., Walgreen Co., and Apollo Pharmacy. They have adopted various strategies including collaborations, partnerships, mergers & acquisitions, new product launches, and others to gain a strong position in the industry.

We also Offers Regional and Country Reports-

Japan UV Infection Control Devices Market
South Korea UV Infection Control Devices Market
Singapore UV Infection Control Devices Market
China UV Infection Control Devices Market
Indonesia UV Infection Control Devices Market
Australia UV Infection Control Devices Market
Taiwan UV Infection Control Devices Market

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Browse more latest healthcare reports:

Brachytherapy Market https://www.alliedmarketresearch.com/brachytherapy-market-A11122

U.S. Home Medical Equipment Market https://www.alliedmarketresearch.com/us-home-medical-equipment-market-A11059

Cancer Diagnostics Market https://www.alliedmarketresearch.com/cancer-diagnostics-market-A11336

AI in Genomics Market https://www.alliedmarketresearch.com/ai-in-genomics-market-A11556

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.